packageImeglimin

imeglimin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Imeglimin is a blood glucose lowering drug investigated for diabetes. It is classed as investigational and is not an approved medicine in major databases.

Summary written by glm-5.3-flash from Wikidata Q6003719 and the WHO ATC classification; not checked by a person.

name:imeglimin
ATC codes:A10BX15
DrugBank:DB12509
PubChem CID:24812808
Wikidata:Q6003719
formula:C6H13N5
molar mass:155.205 g/mol (PubChem CID 24812808)
logP:-1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown